Skip to main content

Insulin Regular News

Technosphere Insulin + Insulin Degludec Noninferior to Usual Care in T1DM

MONDAY, Dec. 16, 2024 – For adults with type 1 diabetes, a regimen of inhaled Technosphere insulin (TI) plus insulin degludec is noninferior to usual care for glycemic control, according to a study...

Automated Insulin Delivery System Improves Glycemic Control in Youth

THURSDAY, Dec. 12, 2024 – Initiation of an automated insulin delivery (AID) system improves glycemic control in children and adolescents with type 1 diabetes (T1D), according to a study published in...

FDA Medwatch Alert: Caution When Using Pen Needles to Inject Medicines: FDA Safety Communication

Audience: Patients and caregivers who use or are considering using pen injectors with pen needles to inject prescription medicines. Health care providers who treat patients, or who train...

U.S. Food And Drug Administration Approves Humulin R U-500 KwikPen

INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's Humulin R U-500 KwikPen (insulin human injection) 500 units/mL, a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Diabetes, Type 2, Diabetes, Type 1, Insulin Resistance

Insulin Regular patient information at Drugs.com